| Literature DB >> 29328503 |
Gaurav Bajaj1, Manish Gupta1, Hwei-Gene Heidi Wang2, Jeffrey S Barrett3, Matthew Tan2, Katrin Rupalla2, Richard Bertz1, Jennifer Sheng1.
Abstract
Cancer is a growing public health problem in China. Despite the high unmet medical need of patients with cancer in China, oncology drug approvals have historically lagged behind those in the West, mainly the United States and Europe. China is currently undertaking regulatory reforms at a fast pace in order to mitigate this lag.Entities:
Mesh：
Substances：
Year: 2018 PMID： 29328503 DOI： 10.1002/cpt.1017
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875